Prognostic role of standard uptake value according to pathologic features of lung adenocarcinoma.


Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
Oct 2022
Historique:
pubmed: 28 5 2021
medline: 24 9 2022
entrez: 27 5 2021
Statut: ppublish

Résumé

To evaluate the influence of lung adenocarcinoma second predominant pattern on the maximal standard uptake value (SUVmax) and its prognostic effect in different histologic groups. We retrospectively collected surgically resected pathologic stage I and II lung adenocarcinoma from nine European institutions. Only patients who underwent preoperative PET-CT and with available information regarding SUVmax of T (SUVmaxT) and N1 (SUVmaxN1) component were included. We enrolled 344 patients with lung adenocarcinoma. SUVmaxT did not show any significant relation according to the second predominant pattern ( SUVmaxT is influenced only by the adenocarcinoma predominant pattern, but not by second predominant pattern. Concurrently, in high-grade predominant pattern and pN1 group the prognostic power of SUVmaxT becomes nonsignificant.

Identifiants

pubmed: 34039110
doi: 10.1177/03008916211018515
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-469

Auteurs

Pietro Bertoglio (P)

Division of Thoracic Surgery, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.

Luigi Ventura (L)

Division of Thoracic Surgery, University Hospital of Parma, Parma, Italy.

Vittorio Aprile (V)

Division of Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.

Maria Angela Cattoni (MA)

Division of Thoracic Surgery, University of Insubria, Varese, Italy.

Dania Nachira (D)

Department of General Thoracic Surgery, Fondazione Policlinico "A. Gemelli"-Catholic University of Sacred Heart, Rome, Italy.

Filippo Lococo (F)

Department of General Thoracic Surgery, Fondazione Policlinico "A. Gemelli"-Catholic University of Sacred Heart, Rome, Italy.

Maria Rodriguez Perez (M)

Division of Thoracic Surgery, Clinica Universidad de Navarra, Madrid, Spain.

Francesco Guerrera (F)

Division of Thoracic Surgery, University of Torino, Torino, Italy.

Fabrizio Minervini (F)

Division of Thoracic Surgery, Cantonal Hospital Lucerne, Lucerne, Switzerland.

Letizia Gnetti (L)

Division of Pathological Anatomy, University Hospital of Parma, Parma, Italy.

Diana Bacchin (D)

Division of Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.

Francesca Franzi (F)

Division of Pathological Anatomy, University of Insubria, Varese, Italy.

Giulia Querzoli (G)

Division of Pathological Anatomy, IRCCS Sacro Cuore Don Calabria Hospital, Negrar Di Valpolicella, Verona, Italy.

Guido Rindi (G)

Division of Pathological Anatomy, Fondazione Policlinico "A.Gemelli"-Catholic University of Sacred Heart, Rome, Italy.

Salvatore Bellafiore (S)

Division of Pathological Anatomy, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.

Federico Femia (F)

Division of Thoracic Surgery, University of Torino, Torino, Italy.

Andrea Viti (A)

Division of Thoracic Surgery, IRCCS Sacro Cuore Don Calabria Hospital, Negrar Di Valpolicella, Verona, Italy.

Peter Kestenholz (P)

Division of Thoracic Surgery, Cantonal Hospital Lucerne, Lucerne, Switzerland.

Enrico Ruffini (E)

Division of Thoracic Surgery, University of Torino, Torino, Italy.

Massimiliano Paci (M)

Division of Thoracic Surgery, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.

Stefano Margaritora (S)

Department of General Thoracic Surgery, Fondazione Policlinico "A. Gemelli"-Catholic University of Sacred Heart, Rome, Italy.

Andrea Selenito Imperatori (AS)

Division of Thoracic Surgery, University of Insubria, Varese, Italy.

Marco Lucchi (M)

Division of Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.

Paolo Carbognani (P)

Division of Thoracic Surgery, University Hospital of Parma, Parma, Italy.

Alberto Claudio Terzi (AC)

Division of Thoracic Surgery, IRCCS Sacro Cuore Don Calabria Hospital, Negrar Di Valpolicella, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH